Fresenius Medical Care AG & Co. FMS reported third-quarter 2025 adjusted earnings per share (EPS) of 64 cents, which surpassed the Zacks Consensus Estimate by 8.47%. The bottom line improved 35.8% ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Fresenius Medical Care (FMS) is rated a 'Buy,' citing strong fundamentals. FMS demonstrates robust revenue growth, margin expansion, and dividend safety, with a new HVHDF product rollout expected to ...

CVS Health CVS and Fresenius Medical Care AG & Co. FMS are two major players in the healthcare services sector, but with distinct areas of focus. CVS Health is a leading health solutions company ...